Sanofi ADR (0A2V)
LSE
39.89
-0.14 (-0.36%)
Closed
Oct 8, 2026
Day's Range
39.5940.20
52 wk Range
39.1952.65
Financial Statements - 0A2V - Sanofi ADR
Revenue
46.71B▼ 11.8%
Net Income
7.85B▲ 16.8%Net Margin 16.8%
EBITDA
15.77B▼ 0.4%
Free Cash Flow
7.21B▲ 2.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 46.71B | 52.99B | 41.61B | 40.56B | 39.17B | 37.36B |
| Cost of Goods | 13.04B | 15.80B | 12.62B | 11.88B | 12.25B | 12.15B |
| Gross Profit | 33.66B | 37.18B | 28.99B | 28.67B | 26.92B | 25.21B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 9.59B | 11.32B | 9.17B | 10.92B | 9.14B | 7.89B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -3.29B | -2.63B | -2.21B | -766M | -979M | 6.22B |
| Pre Tax Income | 6.17B | 8.01B | 6.25B | 9.93B | 7.79B | 13.77B |
| Income Tax | 1.04B | 1.44B | 1.01B | 1.90B | 1.55B | 1.80B |
| Net Income | 7.85B | 6.72B | 5.43B | 8.48B | 6.27B | 12.33B |
| EPS Basic | 3.2 | 2.295 | 2.155 | 3.345 | 2.485 | 4.91 |
| EPS Diluted | 3.2 | 2.295 | 2.15 | 3.33 | 2.485 | 4.91 |
| Basic Shares Outstanding | 2.44B | 2.99B | 2.40B | 2.40B | 2.40B | 2.40B |
| Diluted Shares Outstanding | 2.44B | 2.99B | 2.40B | 2.40B | 2.40B | 2.40B |
| Ebit | 6.80B | 8.91B | 6.96B | 10.40B | 8.18B | 14.21B |
| Ebitda | 15.77B | 15.83B | 13.60B | 14.27B | 12.51B | 11.79B |
| Net Income Continuous Operations | 4.93B | 6.57B | 5.06B | 7.97B | 6.22B | 12.29B |
| Minority Interests | -38M | -58M | -36M | -113M | -56M | -36M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
